Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
NCT06593392Phase 2Recruiting
- Sponsor
- CSL Vifor
- Start
- Aug 2026
- Primary completion
- Aug 2029
- Modality
- Peptides, Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of difelikefalin in pruritus, sponsored by CSL Vifor. Started Aug 2026; status: recruiting.
02
Drugs
difelikefalin
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT06593392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06593392.